Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease - Related Videos
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
0 Views •
Cited by 7 •
2017
This study describes the successful generation of a new chronic obstructive pulmonary disease (COPD) animal model by repeatedly exposing mice to high concentrations of ozone.
01:24
Chronic Obstructive Pulmonary Disease
0 Views •
2026
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction. Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
04:24
Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
0 Views •
2025
This protocol describes the specific process and efficacy of acupoint application in treating fatigue symptoms associated with chronic obstructive pulmonary disease.
01:20
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
0 Views •
2024
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD: Chronic Inflammation • Inhalation of Irritants: Inhaling irritants, especially cigarette smoke, are primary causes of inflammation in COPD. Other irritants can include...
01:23
Chronic Obstructive Pulmonary Disease II: Emphysema
0 Views •
2026
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
FAQs
Chronic inflammation affects COPD through several linked changes rather than one isolated lesion. It narrows the airways, increases mucus production, and damages alveolar walls. Together, these changes reduce expiratory airflow and impair gas exchange. This mechanism explains why the disease can produce persistent respiratory symptoms while also causing progressive functional consequences within the lungs.
Environmental exposures can contribute to the chronic inflammatory process underlying COPD. Continued exposure may interact with airway inflammation and structural lung changes, helping explain why disease burden varies among individuals. Recognizing this relationship supports earlier intervention and encourages clinical care that considers both the patient’s symptoms and the factors associated with lung injury.
Clinicians combine symptom assessment with spirometry to support a COPD diagnosis. Symptoms provide information about the patient’s respiratory experience, whereas spirometry supplies evidence related to airflow limitation. Using both sources helps place the clinical presentation in the context of persistent respiratory impairment, supporting more informed evaluation rather than relying on symptoms alone.
Management may combine smoking cessation, inhaled bronchodilators, pulmonary rehabilitation, vaccination, and selected oxygen therapy. These measures address different clinical needs, including symptom relief, prevention of exacerbations, and preservation of function. The overview supports an individualized approach, so treatment selection depends on the patient’s circumstances rather than applying one intervention uniformly to every case.
Pulmonary rehabilitation is one component of COPD management that can help reduce symptoms and functional decline. Its inclusion alongside inhaled bronchodilators, smoking cessation, vaccination, and selected oxygen therapy reflects a broader care strategy rather than dependence on medication alone. In medicine, this approach supports individualized management of the disease’s effects on respiratory function and daily capability.
Oxygen therapy is used selectively rather than presented as a universal treatment for everyone with COPD. Within the broader management plan, selected oxygen therapy can contribute to reducing symptoms, exacerbations, and functional decline. Its place in care illustrates why COPD treatment requires clinical assessment and individualized decisions, alongside measures such as smoking cessation, rehabilitation, and vaccination.